IPO - Current and Forthcoming
Snapshot
|
Company |
Opens on |
Closes on |
Price band (Rs.) |
Listing |
||
|
27-Sep |
04-Oct |
320-370 |
BSE, NSE |
|||
|
27-Sep |
05-Oct |
35 |
BSE |
|||
For details of each issue, please check below.
Grey Market Premium
|
Issue |
Premium |
|
CCCL |
Rs. 150 |
|
Circuit Systems |
Rs. 4 |
|
Dhanus Tech |
Rs. 55 |
|
Kaveri Seeds |
Rs. 23 |
|
Koutons Retails |
Rs. 70 |
|
Maytas infra |
Rs. 160 |
|
Power Grid Corporation |
Rs. 28 |
|
Saamya Biotech |
Rs. 5 |
|
Supreme Infrastructure |
Rs. 50 |
Power Grid Corporation of India Limited IPO - Listing
|
IPO Listing Date |
05 Oct 2007 |
|
|
BSE Script Code |
532898 |
|
|
NSE Symbol |
POWERGRID |
|
|
Listing in |
A Group of Securities |
|
|
ISIN |
INE752E01010 |
|
|
Issue Price |
Rs. 52- |
|
|
Face Value |
Rs. 10- |
|
Kaveri Seeds IPO - Listing
|
IPO Listing Date |
04 Oct 2007 |
|
BSE Script Code |
Not Available |
|
NSE Symbol |
KSCL |
|
ISIN |
INE455I01011 |
|
Issue Price |
Rs. 170- |
|
Face Value |
Rs. 10- |
Allotment status is available at http://www.bigshareonline.com/IPO/ipostatus.aspx
Maytas Infra IPO – Opens 27 Sep
Maytas Infra, a construction and infrastructure development company, is entering the capital market with an initial public offering of 88.5 lakh equity shares of Rs 10 each for cash at a price to be decided through a 100 per cent book building process. The issue will open for subscription on September 27 and will close on October 4. The company has fixed the price band between Rs 320 and Rs 370 per equity share. Expansion plans The company plans to use the funds to purchase construction equipment, invest in companies, building an elevated road in Bangalore, a coal based electricity generation plant in East Orissa and a coal washery in Chhattisgarh. According to the company, Maytas has undertaken projects in 12 States, including those in irrigation, roads and bridges and other infrastructure sectors. Diversified portfolio The company has diversified its portfolio of construction projects and is also undertaking civil construction projects in power, industrial structures, oil and gas infrastructure and railway sectors. Source: Moneycontrol
Circuit Systems (India) Limited - IPO
Incorporated in 1995, Circuit Systems (India) Limited (CSIL) is in the business of manufacturing Printed Circuit Boards (PCB). CSIL has around 10 years of experience in manufacturing PCB’s. CSIL’s manufacturing plant is located at Gandhinagar, Gujrat. Open : September 27, 2007 to October 05, 2007 Type : Fixed Price Issue (Initial Public Offer IPO) Size: 42,44,810 Equity Shares of Rs. 10/- each Price: Rs. 35/- Per Equity Share Listing : BSE Lead Manager: Centrum Capital Limited Registrar : CAMEO Corporate Services Limited Email: cameo@cameoindia.com
Rajesh Exports to consider 1:2 stock split
Rajesh Exports, the Rs 7,000 crore Bangalore-based jewellery retailer and exporter, has said that it will consider issue of bonus shares and splitting of each equity share of Rs 2 each into 2 shares of Re 1 each. The decision is expected to be considered at the company’s Board meeting on October 22, 2007. The stock is currently trading at Rs 962 on BSE, a 3.5% increase over yesterday’s close.
Exit option for Dhanus Tech IPO investors
Dhanus Tech is allowing investors including institutional bidders to withdraw their IPO applications. The last date for this is 06 October.
Reason for the withdrawal is given different at different sources. Some of these are:
Recent developments relating to Dhanus Technologies (Dhanus) — a company which made a recent initial public offering—may affect investor sentiment towards the stock on listing and lower chances of any potential listing gain. A company statement on Thursday, has drawn attention to issues relating to seizure of calling cards from its premises and CBI raids and subsequent recovery of cash and property documents from its Managing Director. Pursuant to this, the company has provided for time until October 6 2007, allowing investors including institutional bidders to withdraw their IPO applications.
Unattractive offer
In any case, the offer appeared unattractive purely from a business point of view. International calling cards, fleet tracking devices and IT/BPO are the key business segments for the company. With heavy competition from established players in its calling cards division, the relatively small market for fleet tracking in India and less than promising prospects for it’s IT and BPO divisions, there are uncertainties about the company’s ability to deliver sustainable growth. Now, recent developments indicate that there could also be governance issues with respect to the company. In light of this, the exit window provides retail investors an option to exit from this offer.
(Source: Hindu Business Line)
Company said in the statement, “The company denies having obtained any personal loans in the name of its employees without their knowledge and/or by forging their signatures. We wish to clarify that neither our company nor any of our promoters/directors/employees are in any way involved in any of the alleged frauds or forgery mentioned in said article. Individual intimation letters regarding this public notice have been dispatched to all the applicants and the dispatch as been completed on September 26, 2007″.
Earlier, a few newspapers had reported about alleged fraud by the management and applications for personal loans, done by the management, on behalf of the employees without their knowledge.
Sebi has guided the company to come out with an option of giving a window to the investors to move out if they want to. They feel that the information given is not enough to alert the investors. So, it is a statutory provision, which has been asked by Sebi, and they are following it.
(Source Moneycontrol)
Saamya Biotech IPO – Mixed Opinion
There is a mixed opinion about this IPO. Some analyst suggested to apply for the IPO considering that Saamya Biotech has been issued at a reasonable price and the profile of the company is clean considering its directors and have said that people should subscribe with long term view in this IPO.
Finchimica, Spa Italy has 100% buying agreement with Saamya Biotech for anti-cancer drug which would be a fetching point for this company on the long term.
Others says it is not wise to invest in this IPO as the financial performance of this company is not great and in the post paid capital of the company the promoters stake would be only 7%.
Based on the above opinions you can give a miss to this IPO. If you are want to reap the benefit of extra ordinary gains which all IPO listing are giving and are willing to take risk then you may want to apply.
SUPREME INFRASTRUCTURE INDIA LIMITED -Subscription Status
Subscription status of SUPREME INFRASTRUCTURE INDIA LIMITED at the close of the issue:
|
Category |
No. of times issue is subscribed |
|
|
QIBs |
52.1080 |
|
|
Non Institutional |
65.4279 |
|
|
Retail |
48.2283 |
|
|
Employee |
NA |
|
|
Total |
52.75 |
|
Thus for retail investors there is no firm allotment. Even if you have applied for maximum shares i.e. 900 in retail category, you will have to await for lottery since lot size is 60 share (thus max of 15 lots) and retail segment got subscribed 48 times.

